ArticleJournal of mass spectrometry : JMS2026
Proteoform-Resolved Interaction Studies of Plasminogen by CZE-MS and SEC-MS Under Near-Native Conditions.
Article in Journal of mass spectrometry : JMS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Native CZE-MS analysis of antibodies and hemoglobin using protein-adapted CZE and ESI conditions for detailed proteoform characterization.Analytical and bioanalytical chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Native mass spectrometry has become an important technique for studying proteins and protein complexes under physiologically similar conditions. However, the technique is still rarely coupled to separation techniques, as the widely used reversed-phase chromatography mostly denatures proteins. Here we present a study combining both capillary zone electrophoresis and size exclusion chromatography, each coupled online to native electrospray ionization mass spectrometry for the analysis of proteoforms of plasminogen. Plasminogen, the zymogen form of plasmin, is an abundant plasma protein with multiple proteoforms whose activation via proteolytic cleavage is tightly regulated within the fibrinolytic system and is partly modulated by post-translational modifications. Near-native CZE conditions enable the separation of proteoforms differing in phosphorylation and glycosylation, that is, almost baseline separation of proteoforms differing in phosphorylation and sialylation. The nanoflow sheath liquid interface (nanoCEasy) enables efficient ionization as well as the flexibility to ionize under native or denaturing conditions. The CZE-MS set-up can be used to study proteoform-resolved interaction directly in the capillary, as demonstrated for the activation of plasminogen by the co-injection of tissue plasminogen activator (tPA). In these proof-of-concept experiments, various truncations of plasminogen were observed with a preferred cleavage for the N-glycosylated and the phosphorylated proteoforms. SEC-MS enables partial separation of the proteoforms, particularly between glycosylated and nonglycosylated proteoforms leading to the detection of new proteoforms not described by direct infusion experiments. Overall, the combination of near-native CZE-MS and SEC-MS provides a detailed characterization of plasminogen and enables proteoforms-resolved interaction studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.